Next Generation Sequencing Market will experience the highest growth rate of 20.43% during the given forecast period 2014 – 2023

Industry Trend Analysis:
In 2014, the Global Next Generation Sequencing Market was evaluated around USD 2.82 billion and is expected to reach approximately USD 15.04 billion by 2023 while registering itself at a compound annual growth rate (CAGR) of 20.43% over the forecast period.

Use of innovative platforms for the growth of custom-made medicine by clinical analysis at a genetic stage is a major factor that is likely to improve NGS demand during the forecast years. An escalating amount of R&D projects in the areas of transcriptomics, metabolomics, and proteomics are anticipated to fuel the technology demand as well.

Genomics and proteomics function with and on a massive array of structural data that demands to be accumulated and classified through subsequent integrated data analysis and sequence determination. The introduction of novel services and products by well-known market giants is anticipated to boost the growth during the forecast years. Additionally, growing inclination of drug developers and scientists for the NGS technology in an attempt to employ the avenues of tailored medicine has established to be a high rise for demanding these platforms with the aim of gaining penetrations into the genetic enterprises of a huge amount of organisms. This augments in demand is expected to boost the NGS industry over the forecast period.

Competitive Outlook and Trend Analysis:
The major market players in global next-generation sequencing market are Beijing Genomics Institute, Pacific Biosciences, Knome Inc., F Hoffmann-La Roche, Thermo Fisher Scientific, GATC Biotech AG., Oxford Nanopore Technologies Inc., Biomatters Ltd., Agilent Technologies Inc., DNAStar Inc., Helicos BioSciences,CLC Bio (Qiagen), Macrogen Inc., and Illumina Inc. The rivalry between market players seeking to achieve a grip in the rapidly-developing biotech segment is engaging on numerous battlefields. Companies are concentrating on the advent of economical sequencing devices in regular healthcare checkups.

Access Sample Copy of This Report @ https://www.crystalmarketresearch.com/report-sample/HC02601 .

The Global Next Generation Sequencing Market is segmented as follows –

By Application:

Oncology

Clinical Investigation-
Idiopathic Diseases
Inherited Diseases
Infectious Diseases
Non-Communicable / Other Diseases

Reproductive Health-NIPT
PGT
Newborn/Genetic Screening

HLA Typing/Immune System Monitoring

Metagenomics, Epidemiology & Drug Development

Agrigenomics & Forensics

Consumer Genomics

By Technology:
Targeted Sequencing Analysis-
DNA Based Targeted Sequencing Analysis
RNA Based Targeted Sequencing Analysis

Whole Genome Sequencing

Whole Exome Sequencing

By Work flow:
Pre-sequencing-

NGS Library Preparation Kits
NGS Semi-Automated Library Preparation
NGS Automated Library Preparation
Clonal Amplification

Sequencing-
Data Analysis

Primary Data Analysis

Secondary Data Analysis

Tertiary Data Analysis

By End User:
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users

For more information, click on the below link @ https://www.crystalmarketresearch.com/report/next-generation-sequencing-ngs-market .

Table of Contents:
1.Introduction
2.Executive Summary
3.Market Overview
4.Next Generation Sequencing (NGS) Market, By Application4.1.Introduction
4.2.Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Application (2014-2017)
4.3.Next Generation Sequencing (NGS) MarketAssessment and Forecast, By Application, 2014-2023
4.4.Oncology
4.5.Clinical Investigation
4.6.Reproductive Health
4.7.HLA Typing/Immune System Monitoring
4.8.Metagenomics, Epidemiology & Drug Development
4.9.Agrigenomics & Forensics
4.10.Consumer Genomics
5.Next Generation Sequencing (NGS) Market, By Technology5.1.Introduction
5.2.Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share By Technology (2014-2017)
5.3.Next Generation Sequencing (NGS) Market Assessment and Forecast, By Technology, 2014-2023
5.4.Targeted Sequencing Analysis
5.5.Whole Genome Sequencing
5.6.Whole Exome Sequencing
To be Continued…

Ask Questions to Expertise at @ https://www.crystalmarketresearch.com/send-an-enquiry/HC02601 .

Application Outlook and Trend Analysis:Oncology is expected to demonstrate profitable growth in the approaching years owing to the speedily developing of sequencing capabilities that facilitate directed sequence determination of an amount of cancer genes that allow oncologists to acquire genetic data exist in few of the less available dense gene clusters concerning cancer tumors and cells.

Key Growing Factors:An extensive research study on the Market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Next Generation Sequencing Market.

We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

The Next Generation Sequencing Market Report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

To avail discount, please click on the link @ https://www.crystalmarketresearch.com/check-discount/HC02601 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com